Showing results (351-360 of 4,510) with videos related to
Sort By:
Pageof 451
Future Oncology (London, England)|May 9, 2015
Molecular pathogenesis of ovarian clear cell carcinomaIoannis Gounaris, James D BrentonFuture Oncology (London, England)|May 9, 2015
Vismodegib in the treatment of basal cell carcinoma: indications for clinical practicePiergiacomo Calzavara Pinton, Lisa Licitra, Katia Peris, et al.Future Oncology (London, England)|June 4, 2015
US FDA oncology drug approvals in 2014Juliet E Wolford, Krishnansu S TewariFuture Oncology (London, England)|June 5, 2015
Cellular prognostic markers in hepatocellular carcinomaLuigi Buonaguro, Maria Tagliamonte, Annacarmen Petrizzo, et al.Future Oncology (London, England)|June 5, 2015
EGFR mutations in lung cancer: from tissue testing to liquid biopsyFrancesca Fenizia, Antonella De Luca, Raffaella Pasquale, et al.Future Oncology (London, England)|June 5, 2015
An overview of new biomolecular pathways in pathogen-related cancersMaria Lina Tornesello, Luigi Buonaguro, Franco M BuonaguroFuture Oncology (London, England)|June 5, 2015
3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic reviewMarc De Braekeleer, Marie-Josée Le Bris, Etienne De Braekeleer, et al.Future Oncology (London, England)|June 5, 2015
Clinical efficacy of mTOR inhibitors in solid tumors: a systematic reviewZebo Huang, Yinxia Wu, Xin Zhou, et al.Future Oncology (London, England)|August 25, 2025
Tetra-modality bladder preservation with avelumab for muscle-invasive urothelial cancer: a phase II trial (TRIUMPH-B01)Ali Shamseddine, Noura Abbas, Sally Temraz, et al.Future Oncology (London, England)|August 26, 2025
Paclitaxel-based strategy as first-line therapy for advanced breast cancer: a model-based economic evaluation for ChinaJi-Sheng Chen, Jia Hu, Meng-Ting LiPageof 451